Although we observed WFA-mediated immunomodulation was ubiquitous in different types of cancer cells, further in vivo studies are needed to confirm the effectiveness of WFA and α-PD-L1 combination therapy in colorectal and breast cancer. This evidence concerns the gene CD274 and breast cancer.